Drug Profile
Research programme: cytokine and protein and peptide-based therapeutics - Il-Yang
Latest Information Update: 28 Jan 2019
Price :
$50
*
At a glance
- Originator Il-Yang
- Class Cytokines; Peptides
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Unspecified
Most Recent Events
- 28 Jan 2019 No recent reports of development identified for research development in Unspecified in South Korea
- 12 Dec 2014 Early research in Undefined indication in South Korea (unspecified route)